TPO suppression was found to inhibit the proliferation and migration of NSCLC cells by regulating cyclin E1, cyclin E2, CDK2, P27, RhoA, RhoC and c‐Myc protein levels. This evidence concerns the gene CCNE2 and non-small cell lung carcinoma.